An observational study in Neurodegenerative Diseases and Dementia, sponsored by Sykehuset Innlandet HF. Completed at 3 sites in Norway. Per ClinicalTrials.gov, last updated 2023-11-24.
Sponsored by Sykehuset Innlandet HF · Observational
This project is based on a three-year program that aims to improve the knowledge of the socioeconomic consequences of dementia in Norway. By including patients with and without dementia in four different cohorts (from nursing homes, from memory clinics, home-dwelling persons with dementia and elderly persons without dementia), the project's aim is to describe the course of dementia, the economical cost of dementia and to look into possible risk factors for dementia.
2,172 studies on the registry are indexed under Dementia; 540 are open to participants now.
This study's enrollment of 696 is above the median of 250 across 482 observational studies indexed under Dementia.
Browse Dementia studies →Sykehuset Innlandet HF is the lead sponsor of 50 studies on the registry; 9 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Nursing home Memory clinics In-home care Persons without dementia (Control)
Memory clinic sample
Inclusion Criteria:
Exclusion Criteria:
In-home care sample
Inclusion Criteria:
Exclusion Criteria:
Nursing-home sample
Inclusion Criteria:
Exclusion Criteria:
Control sample
Inclusion Criteria:
Exclusion Criteria:
People visiting a memory clinic at Ullevål University Hospital, St Olav Hospital or Innlandet Hospital Trust (n=400). The patients will be assessed three times over a three-year follow-up. Baseline inclusion started in January 2010. The final assessments will take place in spring 2014.
People admitted to a nursing home recruited from municipalities in Hedmark, Oppland, Nord-Trøndelag and Bergen (n=1000). Baseline assessments take place when the person is admitted to the nursing home. The patients will be assessed every six months over a three-year follow-up period. The first participant was included in March 2012, and baseline inclusion will be completed in December 2013.
People 70 years of age or older receiving in-home care recruited from municipalities in Hedmark, Oppland, Oslo, Østfold and Buskerud (n=995). The patients will be assessed three times over a three-year follow-up period. Baseline inclusion started in April 2009 and the final assessments will take place in December 2013.
People without dementia recruited from Nord-Trøndelag, Drammen and Oslo (n=400). The participants will be assessed three times over a three-year follow-up period. Baseline inclusion will take place in autumn 2012 and the last follow-up will take place in autumn 2015.
Cost of dementia
The cost of dementia is assessed with the Resource Utilization in Dementia (RUD) (Wimo et al. 2009), for a period of three years for all the four cohorts. The nursing home cohort is assessed at baseline and every 6 month for three years, the other three cohorts are assessed three times over a three-year follow up period.
Time frame: 3 years
The course of neuropsychiatric symptoms
The course of neuropsychiatric symptoms (depression, anxiety, psychosis, aggression, apathy, and cognition, are assessed with standardized assessment Tools. The nursing home cohort is assessed at baseline and every 6 month for three years, the other three cohorts are assessed three times over a three-year follow up period.
Time frame: 3 years
Quality of Life in persons admitted to nursing homes
Quality of Life is assessed with standardized assessment Tools. The nursing home cohort is assessed at baseline and every 6 month for three years, the other three cohorts are assessed three times over a three-year follow up period.
Time frame: 3 years
Prescription of medication
Prescription of medication is recorded at baseline, and the amount of medication used is recorded throughout the study period. The nursing home cohort is assessed at baseline and every 6 month for three years, the other three cohorts are assessed three times over a three-year follow up period.
Time frame: 3 years
DNA polymorphism
DNA samples are collected for the nursing home cohort, and they are assessed for genetic polymorphism previous associated with dementia. The results are used as covariates in the analyses of the course of the symptoms and to look for risk factors for dementia.
Time frame: At baseline
Organizational factors of the nursing homes
Organizational factors of the nursing homes and variables associated with the staff of the nursing homes will be collected at baseline, and the data will be used to explore associations between nursing home characteristics and the course of the symptoms in the patients.
Time frame: At baseline
Plan to share: Yes — On request
Supporting information: Study protocol, Sap, Icf
This study is completed, as verified in Nov 2023. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Sykehuset Innlandet HF